RecruitingNCT05155267

Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Biomonitoring of Internal Exposure to MNPLs (Micro and NanoPlastics), and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)


Sponsor

Ricard Marcos

Enrollment

50 participants

Start Date

Feb 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Micro and nanoplastics (MNPLs) effects on human heath is still preliminary. Chronic kidney disease (CKD) participants, specially does patients submitted to hemodialysis, are a population high exposed to plastics. The objective of our research is to be able to detect MNPLs on biological fluids of hemodialysis patients as well as their potential genotoxic and immunological damage.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether tiny plastic particles — called microplastics and nanoplastics (MNPLs) — accumulate in the blood of people with chronic kidney disease (CKD), particularly those on dialysis. Researchers want to understand how these environmental particles may affect the health of patients with impaired kidney function. **You may be eligible if...** - You have chronic kidney disease (CKD), either on dialysis for more than 3 months or in the pre-dialysis stage with low kidney function - You are between 18 and 85 years old - Your hemoglobin is stable (above 10 g/dL) - You have no active infection or active cancer - OR you are a healthy control matched for age, sex, and lifestyle **You may NOT be eligible if...** - You are clinically unstable or have a life expectancy under 12 months - You have a bleeding or clotting disorder - You are pregnant - You are currently participating in another clinical study - You have not provided informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiomonitoring study to detect MNPLs in biological samples and study of their health effects

Determination of MNPLs levels, genotoxic damage and immunological effects


Locations(1)

Servicio Murciano de Salud

Murcia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05155267


Related Trials